| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 38 |
| 1 | PREDNISONE | 25 |
| 2 | CETIRIZINE HYDROCHLORIDE | 23 |
| 3 | CETIRIZINE | 21 |
| 4 | ALBUTEROL SULFATE | 20 |
| 5 | LORATADINE | 19 |
| 6 | CETIRIZINE HYDROCHLORIDE ALLERGY | 18 |
| 7 | CETIRIZINE HYDROCHLORIDE TABLETS | 18 |
| 8 | LORATADINE TABLET | 18 |
| 9 | MONTELUKAST SODIUM | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPICAL ANESTHETIC | 2 | 0.0025 |
| 1 | BENZOCAINE | 2 | 0.0020 |
| 2 | CLINDAMYCIN PHOSPHATE | 5 | 0.0009 |
| 3 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 4 | CEFACLOR | 1 | 0.0006 |
| 5 | CETIRIZINE HYDROCHLORIDE TABLETS | 18 | 0.0006 |
| 6 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 6 | 0.0005 |
| 7 | OMALIZUMAB | 38 | 0.0004 |
| 8 | CANDESARTAN | 13 | 0.0004 |
| 9 | LORATADINE TABLET | 18 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 38 |
| 1 | Corticosteroid [EPC] | 26 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 16 |
| 3 | Estrogen [EPC] | 15 |
| 4 | Androgen [EPC] | 11 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 6 | Progestin [EPC] | 5 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 4 |
| 8 | Progestin-containing Intrauterine System [EPC] | 4 |
| 9 | Serotonin Reuptake Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-IgE [EPC] | 38 | 0.0004 |
| 1 | Androgen [EPC] | 11 | 0.0004 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 3 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 16 | 0.0001 |
| 5 | Estrogen [EPC] | 15 | 0.0001 |
| 6 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 4 | 0.0000 |
| 9 | Serotonin Reuptake Inhibitor [EPC] | 4 | 0.0000 |